TVTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.75%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $592,310.91

Travere Therapeutics Insider Trading History Chart

Travere Therapeutics Share Price & Price History

^$6.16

▲ +0.16 (2.67%)

As of 05/2/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Travere Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/11/2024	Christopher R Cline	CFO	Sell	54	$6.74	$363.96	70,849
2/1/2024	Christopher R Cline	CFO	Sell	3,818	$8.53	$32,567.54	70,903
2/1/2024	Eric M. Dube	CEO	Sell	19,122	$8.70	$166,361.40	350,600
2/1/2024	Peter Heerma	Insider	Sell	4,195	$8.53	$35,783.35	99,503
2/1/2024	Sandra Calvin	CAO	Sell	2,820	$8.53	$24,054.60	52,017
2/1/2024	William E. Rote	SVP	Sell	4,764	$8.71	$41,494.44	80,720
1/23/2024	Christopher R Cline	CFO	Sell	853	$9.07	$7,736.71	49,721
1/23/2024	Elizabeth E. Reed	SVP	Sell	2,062	$8.96	$18,475.52	56,034
1/23/2024	Eric M. Dube	CEO	Sell	7,873	$8.96	$70,542.08	234,722
1/23/2024	Peter Heerma	Insider	Sell	1,559	$9.07	$14,140.13	78,698
1/23/2024	Sandra Calvin	CAO	Sell	910	$9.07	$8,253.70	41,337
1/3/2024	Jula Inrig	Insider	Sell	2,069	$9.48	$19,614.12	35,688
10/3/2023	Peter Heerma	Insider	Sell	3,091	$8.25	$25,500.75	80,257
9/5/2023	Christopher R Cline	CFO	Sell	457	$14.71	$6,722.47	50,574
9/5/2023	Eric M. Dube	CEO	Sell	4,455	$14.71	$65,533.05	242,595
9/5/2023	William E. Rote	SVP	Sell	1,815	$14.71	$26,698.65	61,173
5/10/2023	Christopher R Cline	CFO	Sell	455	$16.59	$7,548.45	51,031
5/10/2023	Elizabeth E. Reed	SVP	Sell	825	$16.59	$13,686.75	56,611
5/10/2023	Sandra Calvin	CAO	Sell	436	$16.59	$7,233.24	42,369
4/11/2023	Christopher R Cline	CFO	Sell	47	$21.49	$1,010.03	51,486
2/1/2023	Christopher R Cline	CFO	Sell	1,588	$21.75	$34,539.00	51,533
2/1/2023	Elizabeth E. Reed	SVP	Sell	2,590	$22.25	$57,627.50	57,436
2/1/2023	Eric M. Dube	CEO	Sell	8,196	$22.25	$182,361.00	237,150
2/1/2023	Peter Heerma	Insider	Sell	1,779	$21.75	$38,693.25	82,069
2/1/2023	Sandra Calvin	CAO	Sell	1,671	$21.75	$36,344.25	43,165
1/24/2023	Christopher R Cline	CFO	Sell	852	$21.90	$18,658.80	32,871
1/24/2023	Eric M. Dube	CEO	Sell	6,442	$21.50	$138,503.00	147,846
1/24/2023	Peter Heerma	Insider	Sell	1,550	$21.90	$33,945.00	63,598
1/24/2023	Sandra Calvin	CAO	Sell	905	$21.90	$19,819.50	35,028
1/24/2023	William E. Rote	SVP	Sell	2,062	$21.50	$44,333.00	42,376
1/5/2023	Eric M. Dube	CEO	Sell	5,625	$20.75	$116,718.75	154,288
1/4/2023	Jula Inrig	Insider	Sell	2,051	$20.75	$42,558.25	17,949
10/4/2022	Peter Heerma	Insider	Sell	3,042	$25.68	$78,118.56	65,148
9/13/2022	Sandra Calvin	CAO	Sell	349	$28.00	$9,772.00	35,933
5/11/2022	Steve Aselage	Director	Sell	2,575	$21.92	$56,444.00	146,919
5/11/2022	William E. Rote	SVP	Sell	1,563	$21.71	$33,932.73	43,672
5/10/2022	Laura Clague	CFO	Sell	825	$21.51	$17,745.75	37,030
5/10/2022	Sandra Calvin	CAO	Sell	436	$21.51	$9,378.36	36,178
1/31/2022	Elizabeth E. Reed	SVP	Sell	1,350	$27.40	$36,990.00
1/31/2022	Eric M. Dube	CEO	Sell	4,813	$27.40	$131,876.20
1/31/2022	Laura Clague	CFO	Sell	1,238	$27.40	$33,921.20
1/31/2022	Peter Heerma	Insider	Sell	1,125	$27.40	$30,825.00
1/31/2022	Sandra Calvin	CAO	Sell	798	$26.51	$21,154.98
1/24/2022	Eric M. Dube	CEO	Sell	7,873	$24.98	$196,667.54
1/24/2022	Laura Clague	CFO	Sell	2,063	$24.98	$51,533.74
1/24/2022	Sandra Calvin	CAO	Sell	934	$24.58	$22,957.72
1/24/2022	William E. Rote	SVP	Sell	1,875	$24.98	$46,837.50
1/11/2022	Elizabeth E. Reed	SVP	Sell	5,000	$27.40	$137,000.00
1/11/2022	Laura Clague	CFO	Sell	7,500	$27.40	$205,500.00
1/4/2022	Eric M. Dube	CEO	Sell	4,832	$30.43	$147,037.76
11/16/2021	Steve Aselage	Director	Sell	31,800	$29.39	$934,602.00
11/5/2021	Steve Aselage	Director	Sell	10,000	$26.23	$262,300.00
10/7/2021	Steve Aselage	Director	Sell	60,000	$26.25	$1,575,000.00
8/17/2021	Eric M. Dube	CEO	Sell	7,836	$17.12	$134,152.32	164,751
8/17/2021	Peter Heerma	Insider	Sell	1,407	$17.12	$24,087.84
7/28/2021	Noah L. Rosenberg	Insider	Sell	1,250	$13.81	$17,262.50
6/2/2021	Eric M. Dube	CEO	Sell	9,562	$14.62	$139,796.44

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Travere Therapeutics (NASDAQ:TVTX)

Institutional Buying and Selling by Quarter

Travere Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/1/2024	Oak Ridge Investments LLC	65,926	$0.51M	0.1%	+13.3%	0.087%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	50,178	$0.39M	0.0%	+8.1%	0.066%
4/29/2024	China Universal Asset Management Co. Ltd.	14,652	$0.11M	0.0%	+68.6%	0.019%
4/24/2024	Assenagon Asset Management S.A.	218,680	$1.69M	0.0%	-13.9%	0.287%
4/23/2024	Rice Hall James & Associates LLC	73,400	$0.57M	0.0%	+4.5%	0.096%
4/17/2024	Hennion & Walsh Asset Management Inc.	40,790	$0.31M	0.0%	+14.4%	0.054%
4/5/2024	Los Angeles Capital Management LLC	93,417	$0.72M	0.0%	N/A	0.123%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	635,277	$5.71M	0.0%	N/A	0.835%
2/26/2024	Virtu Financial LLC	19,498	$0.18M	0.0%	N/A	0.026%
2/20/2024	Quarry LP	4,500	$40K	0.0%	-55.0%	0.006%
2/15/2024	Parkman Healthcare Partners LLC	1,018,812	$9.16M	1.3%	+76.4%	1.356%
2/15/2024	Birchview Capital LP	122,000	$1.10M	0.9%	+48.8%	0.162%
2/14/2024	Avidity Partners Management LP	827,010	$7.44M	0.3%	-37.5%	1.101%
2/14/2024	Pennant Investors LP	55,800	$0.50M	0.1%	N/A	0.074%
2/14/2024	Kynam Capital Management LP	2,000,000	$17.98M	2.0%	+105.6%	2.661%
2/14/2024	Sectoral Asset Management Inc.	274,623	$2.47M	1.1%	N/A	0.365%
2/13/2024	Tower Research Capital LLC TRC	6,033	$54K	0.0%	-23.9%	0.008%
2/13/2024	Armistice Capital LLC	7,384,000	$66.38M	0.9%	-1.5%	9.826%
2/13/2024	Rafferty Asset Management LLC	429,161	$3.86M	0.0%	+18.6%	0.571%
2/13/2024	Finepoint Capital LP	1,435,321	$12.90M	3.7%	+60.2%	1.910%
2/12/2024	Crestline Management LP	81,423	$0.73M	0.1%	+32.6%	0.108%
2/9/2024	GW&K Investment Management LLC	318,266	$2.86M	0.0%	-5.7%	0.424%
2/9/2024	Dynamic Technology Lab Private Ltd	15,221	$0.14M	0.0%	N/A	0.020%
2/8/2024	Panagora Asset Management Inc.	84,909	$0.76M	0.0%	-66.3%	0.113%
2/7/2024	Jump Financial LLC	19,424	$0.18M	0.0%	-89.7%	0.026%
2/7/2024	Teacher Retirement System of Texas	17,001	$0.15M	0.0%	-9.6%	0.023%
2/7/2024	E Fund Management Co. Ltd.	22,910	$0.21M	0.0%	+23.2%	0.030%
2/6/2024	Charles Schwab Investment Management Inc.	539,487	$4.85M	0.0%	-4.7%	0.718%
2/5/2024	Russell Investments Group Ltd.	103,012	$0.93M	0.0%	+5.6%	0.137%
2/1/2024	Signaturefd LLC	3,021	$27K	0.0%	+1,656.4%	0.004%
1/30/2024	Vontobel Holding Ltd.	287,423	$2.58M	0.0%	N/A	0.382%
1/25/2024	Nisa Investment Advisors LLC	5,650	$51K	0.0%	+968.1%	0.008%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	46,424	$0.42M	0.0%	+7.1%	0.062%
1/24/2024	DekaBank Deutsche Girozentrale	30,000	$0.28M	0.0%	N/A	0.040%
1/24/2024	Arizona State Retirement System	20,969	$0.19M	0.0%	+9.7%	0.028%
1/24/2024	China Universal Asset Management Co. Ltd.	8,690	$78K	0.0%	+353.3%	0.012%
1/16/2024	Oak Ridge Investments LLC	58,182	$0.52M	0.1%	-21.7%	0.077%
12/18/2023	Vanguard Group Inc.	4,667,458	$41.73M	0.0%	+10.9%	6.211%
11/17/2023	Jacobs Levy Equity Management Inc.	1,671,770	$14.95M	0.1%	+9.6%	2.225%
11/15/2023	Armistice Capital LLC	7,500,000	$67.05M	1.0%	+0.7%	9.980%
11/15/2023	Affinity Asset Advisors LLC	100,000	$0.89M	0.3%	N/A	0.133%
11/14/2023	Schonfeld Strategic Advisors LLC	524,000	$4.69M	0.0%	+71.4%	0.697%
11/14/2023	Corton Capital Inc.	29,796	$0.27M	0.1%	N/A	0.040%
11/14/2023	Avidity Partners Management LP	1,323,000	$11.83M	0.5%	N/A	1.760%
11/14/2023	Profund Advisors LLC	60,983	$0.55M	0.0%	-32.2%	0.081%
11/13/2023	Algert Global LLC	79,370	$0.71M	0.0%	+51.8%	0.106%
11/13/2023	Federated Hermes Inc.	97,491	$0.87M	0.0%	N/A	0.130%
11/13/2023	Dark Forest Capital Management LP	28,083	$0.25M	0.0%	N/A	0.037%
11/13/2023	Hsbc Holdings PLC	43,877	$0.40M	0.0%	+101.5%	0.058%
11/13/2023	Invesco Ltd.	813,252	$7.27M	0.0%	+16.2%	1.082%
11/13/2023	Rafferty Asset Management LLC	361,993	$3.24M	0.0%	-27.3%	0.482%
11/13/2023	E Fund Management Co. Ltd.	18,596	$0.17M	0.0%	-30.6%	0.025%
11/9/2023	Canada Pension Plan Investment Board	224,000	$2M	0.0%	N/A	0.299%
11/8/2023	State of New Jersey Common Pension Fund D	189,415	$1.69M	0.0%	N/A	0.253%
11/8/2023	Charles Schwab Investment Management Inc.	565,919	$5.06M	0.0%	+4.7%	0.754%
11/8/2023	Swiss National Bank	147,600	$1.32M	0.0%	+7.0%	0.197%
11/8/2023	New York Life Investment Management LLC	15,831	$0.14M	0.0%	-13.6%	0.021%
11/7/2023	Virtus ETF Advisers LLC	17,981	$0.16M	0.1%	-11.5%	0.024%
11/7/2023	New York State Common Retirement Fund	25,768	$0.23M	0.0%	-51.3%	0.034%
11/7/2023	Barclays PLC	288,654	$2.58M	0.0%	+14.3%	0.385%
11/7/2023	Jump Financial LLC	188,925	$1.69M	0.1%	+232.3%	0.252%
11/6/2023	Assenagon Asset Management S.A.	254,051	$2.27M	0.0%	-76.9%	0.339%
10/31/2023	Teacher Retirement System of Texas	18,804	$0.17M	0.0%	+9.6%	0.025%
10/31/2023	Panagora Asset Management Inc.	252,298	$2.26M	0.0%	-13.7%	0.336%
10/30/2023	Oak Ridge Investments LLC	74,314	$0.66M	0.1%	-3.0%	0.099%
10/27/2023	Hennion & Walsh Asset Management Inc.	75,873	$0.68M	0.0%	-6.4%	0.101%
10/27/2023	Cheyne Capital Management UK LLP	26,200	$0.23M	0.7%	N/A	0.035%
10/27/2023	Emerald Mutual Fund Advisers Trust	764,603	$6.84M	0.4%	+44.4%	1.019%
10/26/2023	Emerald Advisers LLC	1,060,302	$9.48M	0.5%	+64.9%	1.414%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	43,341	$0.39M	0.0%	-10.9%	0.058%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	16,511	$0.15M	0.0%	+32.0%	0.022%
10/24/2023	Bank of New York Mellon Corp	245,978	$2.20M	0.0%	-0.9%	0.328%
10/13/2023	SG Americas Securities LLC	131,891	$1.18M	0.0%	N/A	0.176%
8/15/2023	Sphera Funds Management LTD.	213,462	$3.28M	0.5%	+13.8%	0.285%
8/15/2023	Hudson Bay Capital Management LP	444,031	$6.82M	0.0%	N/A	0.592%
8/15/2023	Kynam Capital Management LP	1,454,730	$22.35M	3.1%	-7.0%	1.939%
8/14/2023	Great Point Partners LLC	60,000	$0.92M	0.2%	-94.0%	0.080%
8/14/2023	UniSuper Management Pty Ltd	357,103	$5.49M	0.0%	N/A	0.476%
8/14/2023	Deep Track Capital LP	7,370,000	$113.20M	5.2%	+19.9%	9.825%
8/14/2023	Graham Capital Management L.P.	35,358	$0.54M	0.0%	N/A	0.047%
8/11/2023	Renaissance Technologies LLC	1,555,013	$23.89M	0.0%	-27.5%	2.073%
8/11/2023	Natixis	135,000	$2.07M	0.0%	+235.0%	0.180%
8/11/2023	Panagora Asset Management Inc.	292,382	$4.49M	0.0%	+44.7%	0.390%
8/11/2023	Sectoral Asset Management Inc.	435,313	$6.69M	1.1%	+21.4%	0.580%
8/11/2023	Huntington National Bank	1,943	$30K	0.0%	+57.8%	0.003%
8/11/2023	Trexquant Investment LP	120,990	$1.86M	0.0%	+61.6%	0.161%
8/11/2023	E Fund Management Co. Ltd.	26,794	$0.41M	0.0%	+44.6%	0.036%
8/11/2023	ExodusPoint Capital Management LP	396,060	$6.08M	0.0%	N/A	0.528%
8/10/2023	MetLife Investment Management LLC	38,438	$0.59M	0.0%	+18.2%	0.051%
8/10/2023	ProShare Advisors LLC	14,301	$0.22M	0.0%	+21.9%	0.019%
8/10/2023	Profund Advisors LLC	89,930	$1.38M	0.1%	+48.6%	0.120%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	48,667	$0.75M	0.0%	+10.9%	0.065%
8/10/2023	Russell Investments Group Ltd.	96,742	$1.49M	0.0%	+0.8%	0.129%
8/9/2023	Swiss National Bank	137,900	$2.12M	0.0%	-2.0%	0.184%
8/8/2023	Fisher Asset Management LLC	43,182	$0.66M	0.0%	-26.7%	0.058%
8/8/2023	Rhumbline Advisers	113,443	$1.74M	0.0%	+15.9%	0.152%
8/8/2023	International Biotechnology Trust PLC	441,019	$6.77M	2.1%	+212.7%	0.591%
8/7/2023	Principal Financial Group Inc.	18,382	$0.28M	0.0%	+15.4%	0.025%
8/7/2023	Oak Ridge Investments LLC	76,615	$1.18M	0.1%	-4.3%	0.103%
8/7/2023	New York Life Investment Management LLC	18,325	$0.28M	0.0%	-11.2%	0.025%

Data available starting January 2016

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Today's Range

Now: $6.16

$5.79

$6.21

50 Day Range

MA: $7.13

$5.26

$8.71

52 Week Range

Now: $6.16

$5.12

$19.54

Volume

823,572 shs

Average Volume

1,437,722 shs

Market Capitalization

$468.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Travere Therapeutics?: Travere Therapeutics' top insider investors include:
Eric M Dube (CEO)
Steve Aselage (Director)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Elizabeth E Reed (SVP)
Sandra Calvin (CAO)
Laura Clague (CFO)
Jula Inrig (Insider)
Learn More about top insider investors at Travere Therapeutics.
Who are the major institutional investors of Travere Therapeutics?: Travere Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.29%
Los Angeles Capital Management LLC — 0.12%
Rice Hall James & Associates LLC — 0.10%
Oak Ridge Investments LLC — 0.09%
Mirae Asset Global Investments Co. Ltd. — 0.07%
Hennion & Walsh Asset Management Inc. — 0.05%
Learn More about top institutional investors of Travere Therapeutics stock.
Which institutional investors are selling Travere Therapeutics stock?: In the previous quarter, TVTX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
In the previous year, company insiders that have sold Travere Therapeutics company stock include:
Eric M Dube (CEO)
Steve Aselage (Director)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Elizabeth E Reed (SVP)
Sandra Calvin (CAO)
Learn More investors selling Travere Therapeutics stock.
Which institutional investors are buying Travere Therapeutics stock?: In the last quarter, TVTX stock was bought by institutional investors including:
Los Angeles Capital Management LLC
Oak Ridge Investments LLC
China Universal Asset Management Co. Ltd.
Hennion & Walsh Asset Management Inc.
Mirae Asset Global Investments Co. Ltd.
Rice Hall James & Associates LLC